Cargando…
P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431517/ http://dx.doi.org/10.1097/01.HS9.0000970652.81324.da |
| _version_ | 1785091220900413440 |
|---|---|
| author | Garcia-Guiñon, Antonio Andrea Charry, Paola Moraima Jimenez, Maria Sarra Escarre, Jose Delgado, Izarbe de la Torre, Laura Segura Santaliestra Tomas, Marta Garcia Pintos, Marta Gonzalez Montes, Yolanda Magan, Maria Alicia Senin Motllo, Cristina Ben Azaiz, Randa Elena Cabezudo, Maria Granell Gorrochategui, Miquel Sancho, Esther Jose Herranz, Maria Seres, Yasmina Gironella, Mercedes Soler, Juan A Tutusaus, Jose Maria Marti Abella Monreal, Eugenia Fernandez de Larrea, Carlos |
| author_facet | Garcia-Guiñon, Antonio Andrea Charry, Paola Moraima Jimenez, Maria Sarra Escarre, Jose Delgado, Izarbe de la Torre, Laura Segura Santaliestra Tomas, Marta Garcia Pintos, Marta Gonzalez Montes, Yolanda Magan, Maria Alicia Senin Motllo, Cristina Ben Azaiz, Randa Elena Cabezudo, Maria Granell Gorrochategui, Miquel Sancho, Esther Jose Herranz, Maria Seres, Yasmina Gironella, Mercedes Soler, Juan A Tutusaus, Jose Maria Marti Abella Monreal, Eugenia Fernandez de Larrea, Carlos |
| author_sort | Garcia-Guiñon, Antonio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104315172023-08-17 P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. Garcia-Guiñon, Antonio Andrea Charry, Paola Moraima Jimenez, Maria Sarra Escarre, Jose Delgado, Izarbe de la Torre, Laura Segura Santaliestra Tomas, Marta Garcia Pintos, Marta Gonzalez Montes, Yolanda Magan, Maria Alicia Senin Motllo, Cristina Ben Azaiz, Randa Elena Cabezudo, Maria Granell Gorrochategui, Miquel Sancho, Esther Jose Herranz, Maria Seres, Yasmina Gironella, Mercedes Soler, Juan A Tutusaus, Jose Maria Marti Abella Monreal, Eugenia Fernandez de Larrea, Carlos Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431517/ http://dx.doi.org/10.1097/01.HS9.0000970652.81324.da Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Garcia-Guiñon, Antonio Andrea Charry, Paola Moraima Jimenez, Maria Sarra Escarre, Jose Delgado, Izarbe de la Torre, Laura Segura Santaliestra Tomas, Marta Garcia Pintos, Marta Gonzalez Montes, Yolanda Magan, Maria Alicia Senin Motllo, Cristina Ben Azaiz, Randa Elena Cabezudo, Maria Granell Gorrochategui, Miquel Sancho, Esther Jose Herranz, Maria Seres, Yasmina Gironella, Mercedes Soler, Juan A Tutusaus, Jose Maria Marti Abella Monreal, Eugenia Fernandez de Larrea, Carlos P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title | P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title_full | P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title_fullStr | P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title_full_unstemmed | P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title_short | P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. |
| title_sort | p937: carfilzomib, lenalidomide plus dexamethasone (krd) in relapsed/refractory multiple myeloma patients: update analysis of real-life experience of gemmac group. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431517/ http://dx.doi.org/10.1097/01.HS9.0000970652.81324.da |
| work_keys_str_mv | AT garciaguinonantonio p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT andreacharrypaola p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT moraimajimenezmaria p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT sarraescarrejose p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT delgadoizarbe p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT delatorrelaurasegura p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT santaliestratomasmarta p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT garciapintosmarta p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT gonzalezmontesyolanda p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT maganmariaaliciasenin p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT motllocristina p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT benazaizranda p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT elenacabezudomaria p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT granellgorrochateguimiquel p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT sanchoesther p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT joseherranzmaria p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT seresyasmina p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT gironellamercedes p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT solerjuana p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT tutusausjosemariamarti p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT abellamonrealeugenia p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup AT fernandezdelarreacarlos p937carfilzomiblenalidomideplusdexamethasonekrdinrelapsedrefractorymultiplemyelomapatientsupdateanalysisofreallifeexperienceofgemmacgroup |